Skip to content

Evaluation of dosage in Intravenous Patient-Controlled Analgesia for Post-Cesarean Section Pain Managem

Effects of continuous infusion of intravenous patient-controlled analgesia in postoperative pain management of elective cesarean section: a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008769
Enrollment
48
Registered
2023-09-07
Start date
2022-11-18
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The administration protocol for IVA was as follows: - Prepare a mixture of fentanyl 2250 mcg, nefopam 60 mg, paracetamol 3 g, and ramocetron 0.6 mg in 150 ml of normal saline solution. - Set t

Sponsors

Samsung Changwon Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patient scheduled for elective cesarean section and prescribed intravenous patient-controlled analgesia

Exclusion criteria

Exclusion criteria: Patients with a history of allergies to opioids, non-opioid analgesics and local anesthetics, drug abuse, without continuous would infusion catheter, and undergoing emergency CS

Design outcomes

Primary

MeasureTime frame
Opioid consumption and VAS score

Secondary

MeasureTime frame
opioid induced side effects;need for rescue analgecis

Countries

Korea, Republic of

Contacts

Public ContactJeong Yeon Kim

Samsung Changwon Medical Center

gojy87@naver.com+82-55-233-6048

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026